National Health Investors, Inc. (NYSE:NHI) has received an average rating of “Hold” from the eleven analysts that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $79.17.

Several research analysts have issued reports on NHI shares. BMO Capital Markets restated a “hold” rating and issued a $80.00 price target on shares of National Health Investors in a research report on Wednesday, October 18th. Zacks Investment Research lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. BidaskClub raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research note on Thursday, August 17th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $82.00 price objective on shares of National Health Investors in a research note on Wednesday, October 4th. Finally, SunTrust Banks, Inc. began coverage on shares of National Health Investors in a research note on Tuesday, October 10th. They issued a “hold” rating and a $80.00 price objective for the company.

ILLEGAL ACTIVITY NOTICE: “National Health Investors, Inc. (NHI) Receives Consensus Rating of “Hold” from Brokerages” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/national-health-investors-inc-nhi-receives-consensus-rating-of-hold-from-brokerages/1716357.html.

National Health Investors (NYSE:NHI) traded up $0.09 during trading on Monday, reaching $77.88. 79,224 shares of the company’s stock traded hands, compared to its average volume of 210,186. The company has a debt-to-equity ratio of 0.84, a quick ratio of 12.72 and a current ratio of 12.72. The firm has a market capitalization of $3,230.79, a price-to-earnings ratio of 14.93, a price-to-earnings-growth ratio of 3.85 and a beta of 0.58. National Health Investors has a 12-month low of $68.75 and a 12-month high of $81.21.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a yield of 4.88%. The ex-dividend date of this dividend is Thursday, December 28th. National Health Investors’s dividend payout ratio is 95.00%.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the transaction, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 5.19% of the company’s stock.

Several large investors have recently modified their holdings of the business. US Bancorp DE boosted its stake in shares of National Health Investors by 0.5% during the 2nd quarter. US Bancorp DE now owns 8,836 shares of the real estate investment trust’s stock valued at $700,000 after buying an additional 44 shares during the period. Woodmont Investment Counsel LLC boosted its stake in shares of National Health Investors by 1.3% during the 2nd quarter. Woodmont Investment Counsel LLC now owns 3,414 shares of the real estate investment trust’s stock valued at $270,000 after buying an additional 45 shares during the period. Teacher Retirement System of Texas boosted its stake in shares of National Health Investors by 2.0% during the 2nd quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after buying an additional 62 shares during the period. QS Investors LLC boosted its stake in shares of National Health Investors by 0.8% during the 2nd quarter. QS Investors LLC now owns 7,934 shares of the real estate investment trust’s stock valued at $628,000 after buying an additional 62 shares during the period. Finally, Lee Financial Co boosted its stake in shares of National Health Investors by 1.1% during the 2nd quarter. Lee Financial Co now owns 8,878 shares of the real estate investment trust’s stock valued at $703,000 after buying an additional 95 shares during the period. 68.08% of the stock is owned by institutional investors.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.